Evan Kearns - 26 Dec 2025 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Legal Officer
Signature
/s/ Evan D. Kearns
Issuer symbol
COGT
Transactions as of
26 Dec 2025
Transactions value $
-$2,515,500
Form type
4
Filing time
30 Dec 2025, 16:01:08 UTC
Previous filing
19 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kearns Evan Chief Legal Officer C/O COGENT BIOSCIENCES, INC., 275 WYMAN STREET, 3RD FLOOR, WALTHAM /s/ Evan D. Kearns 30 Dec 2025 0001745285

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COGT Common Stock Sale -$2,515,500 -65,000 -37% $38.7 109,398 26 Dec 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.52 to $38.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions.